Time matters for reducing risk of stroke

The Lancet Neurology

Volumn 9, Issue 5, 2010, Pages 451-453

  Kaste, Markku ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; DISEASE SEVERITY; EMERGENCY WARD; HEALTH SERVICE; HOSPITAL ADMISSION; HUMAN; LETTER; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; TRANSIENT ISCHEMIC ATTACK;

ASPIRIN; DRUG THERAPY, COMBINATION; HUMANS; ISCHEMIC ATTACK, TRANSIENT; RISK; STROKE; TICLOPIDINE;

EID: 77950629795     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(10)70084-3     Document Type: Letter

References (18)

1. Wong K.S.L., Chen C., Fu J., et al., for the CLAIR study investigators. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial. Lancet Neurol (2010) 10.1016/S1474-4422(10)70060-0 published online March 23.
2. Spence J.D., Coates V., Li H., et al. Effects of intensive medical therapy on microemboli and cardiovascular risk in asymptomatic carotid stenosis. Arch Neurol 67 (2010) 180-186
3. Diener H.C., Bogousslavsky J., Brass L.M., et al., for the MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 364 (2004) 331-337
4. Bhatt D.L., Fox K.A., Hacke W., et al., for the CHARISMA Investigators. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 354 (2006) 1706-1717
5. Braunwald E., Angiolillo D., Bates E., et al. Antiplatelet strategies: evaluating their current role in the setting of acute coronary syndromes. Clin Cardiol 31 suppl 1 (2008) I2-I9
6. Johnston S.C., Gress D.R., Browner W.S., and Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA 284 (2000) 2901-2906
7. Rothwell P.M., Buchan A., and Johnston S.C. Recent advances in management of transient ischaemic attacks and minor ischaemic strokes. Lancet Neurol 5 (2006) 323-331
8. Rothwell P.M., Giles M.F., Chandratheva A., et al., for Early use of Existing Preventive Strategies for Stroke (EXPRESS) study. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet 370 (2007) 1432-1442
9. Lee H.Y., Hwang J.S., Jeng J.S., and Wang J.D. Quality-adjusted life expectancy (QALE) and loss of QALE for patients with ischemic stroke and intracerebral hemorrhage. A 13-year follow-up. Stroke (2010) 10.1161/STROKEAHA.109.573543 published online Feb 11.
10. Kotila M., Numminen H., Waltimo O., and Kaste M. Depression after stroke: results of the FINNSTROKE Study. Stroke 29 (1998) 368-372
11. Berg A., Palomäki H., Lönnqvist J., Lehtihalmes M., and Kaste M. Depression among caregivers of stroke survivors. Stroke 36 (2005) 639-643
12. Haley W.E., Roth D.L., Howard G., and Safford M.M. Caregiving strain and estimated risk for stroke and coronary heart disease among spouse caregivers: differential effects by race and sex. Stroke 41 (2010) 331-336
13. Matchar D.B. The value of stroke prevention and treatment. Neurology 51 suppl 3 (1998) S31-S35
14. Lundström E., Smits A., Borg J., and Terént A. Four-fold increase in direct costs of stroke survivors with spasticity compared with stroke survivors without spasticity: the first year after the event. Stroke 41 (2010) 319-324
15. Lavallée P.C., Meseguer E., Abboud H., et al. A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol 6 (2007) 953-960
16. Leys D., Ringelstein E.B., Kaste M., Hacke W., and for the Executive Committee of the European Stroke Initiative. Facilities available in European hospitals treating stroke patients. Stroke 38 (2007) 2985-2991
17. 2 score predicts patients most likely to have true transient ischemic attack. Stroke 39 (2008) 3096-3098
18. Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial, a randomized, double-blind, multicenter clinical trial. http://clinicaltrials.gov/ct2/show/NCT00991029 (accessed March 11, 2010).